Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors. | Biomedicines | 2021 | 33801049 | PubTator, text mining | PubMed |
| Translating Molecular Profiling of Soft Tissue Sarcomas into Daily Clinical Practice. | Diagnostics (Basel) | 2021 | 33799327 | PubTator, text mining | PubMed |
| The MSP-RON pathway regulates liver fibrosis through transforming growth factor beta-dependent epithelial-mesenchymal transition. | Liver Int | 2021 | 33786995 | PubTator, text mining | PubMed |
| Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. | Front Oncol | 2021 | 33777805 | PubTator, text mining | PubMed |
| A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed. | BMC Cancer | 2021 | 33761908 | PubTator, text mining | PubMed |
| A selective small-molecule inhibitor of c-Met suppresses keloid fibroblast growth in vitro and in a mouse model. | Sci Rep | 2021 | 33750878 | PubTator, text mining | PubMed |
| Quantitative proteome profiling stratifies fibroepithelial lesions of the breast. | Oncotarget | 2021 | 33747363 | PubTator, text mining | PubMed |
| The scrambled story between hyaluronan and glioblastoma. | J Biol Chem | 2021 | 33744285 | PubTator, text mining | PubMed |
| Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function. | Elife | 2021 | 33720009 | PubTator, text mining | PubMed |
| Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection. | Front Mol Biosci | 2021 | 33693030 | PubTator, text mining | PubMed |
| Molecular biology of Hodgkin lymphoma. | Leukemia | 2021 | 33686198 | PubTator, text mining | PubMed |
| Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer. | Int J Mol Sci | 2021 | 33673346 | PubTator, text mining | PubMed |
| An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. | Breast Cancer Res | 2021 | 33663560 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention. | J Exp Clin Cancer Res | 2021 | 33648524 | PubTator, text mining | PubMed |
| Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer. | Ther Adv Med Oncol | 2021 | 33643443 | PubTator, text mining | PubMed |
| Alternative splicing and cancer: a systematic review. | Signal Transduct Target Ther | 2021 | 33623018 | PubTator, text mining | PubMed |
| Drivers of Gene Expression Dysregulation in Pancreatic Cancer. | Trends Cancer | 2021 | 33618999 | PubTator, text mining | PubMed |
| Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. | Cancer Sci | 2021 | 33605517 | PubTator, text mining | PubMed |
| Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met. | Sci Rep | 2021 | 33574356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=28